跳至主導覽 跳至搜尋 跳過主要內容

Epigenome-wide association study on asthma and chronic obstructive pulmonary disease overlap reveals aberrant DNA methylations related to clinical phenotypes

  • Taiwan Clinical Trial Consortium of Respiratory Disease (TCORE) group
  • Chang Gung University
  • Chang Gung University of Science and Technology
  • National Yang Ming Chiao Tung University
  • I-Shou University
  • National Taiwan University
  • Veterans General Hospital-Taipei
  • Far Eastern Memorial Hospital
  • Veterans General Hospital-Taichung Taiwan
  • China Medical University Taichung
  • National Cheng Kung University
  • Cartinal Tien Hospital
  • Changhua Christian Hospital
  • National Health Research Institutes Taiwan
  • Kaohsiung Medical University

研究成果: 期刊稿件 › 文章 › 同儕審查

29 引文 斯高帕斯(Scopus)

摘要

We hypothesized that epigenetics is a link between smoking/allergen exposures and the development of Asthma and chronic obstructive pulmonary disease (ACO). A total of 75 of 228 COPD patients were identified as ACO, which was independently associated with increased exacerbations. Microarray analysis identified 404 differentially methylated loci (DML) in ACO patients, and 6575 DML in those with rapid lung function decline in a discovery cohort. In the validation cohort, ACO patients had hypermethylated PDE9A (+ 30,088)/ZNF323 (− 296), and hypomethylated SEPT8 (− 47) genes as compared with either pure COPD patients or healthy non-smokers. Hypermethylated TIGIT (− 173) gene and hypomethylated CYSLTR1 (+ 348)/CCDC88C (+ 125,722)/ADORA2B (+ 1339) were associated with severe airflow limitation, while hypomethylated IFRD1 (− 515) gene with frequent exacerbation in all the COPD patients. Hypermethylated ZNF323 (− 296) / MPV17L (+ 194) and hypomethylated PTPRN2 (+ 10,000) genes were associated with rapid lung function decline. In vitro cigarette smoke extract and ovalbumin concurrent exposure resulted in specific DNA methylation changes of the MPV17L / ZNF323 genes, while 5-aza-2′-deoxycytidine treatment reversed promoter hypermethylation-mediated MPV17L under-expression accompanied with reduced apoptosis and decreased generation of reactive oxygen species. Aberrant DNA methylations may constitute a determinant for ACO, and provide a biomarker of airflow limitation, exacerbation, and lung function decline.

原文英語
文章編號5022
期刊Scientific Reports
卷11
發行號1
DOIs
出版品狀態已出版 - 12 2021

文獻附註

Publisher Copyright:
© 2021, The Author(s).

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG3 健康與福祉
    SDG3 健康與福祉

指紋

深入研究「Epigenome-wide association study on asthma and chronic obstructive pulmonary disease overlap reveals aberrant DNA methylations related to clinical phenotypes」主題。共同形成了獨特的指紋。

引用此